40690-74-2 Usage
Description
1,2:5,6-di-O-isopropylidene-3-O-acrylate-α-D-glucopentoaldo-1,4-furanose is a complex carbohydrate monomer that can be used to synthesize glycopolymers. It is characterized by its unique structure, which includes isopropylidene groups and an acrylate group, making it suitable for various applications in different industries.
Uses
1. Used in Polymer Synthesis:
1,2:5,6-di-O-isopropylidene-3-O-acrylate-α-D-glucopentoaldo-1,4-furanose is used as a monomer for the synthesis of well-defined glycopolymers. The presence of the acrylate group allows for controlled radical polymerization techniques such as NMP, RAFT, or ATRP to be employed, resulting in glycopolymers with specific properties and applications.
2. Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1,2:5,6-di-O-isopropylidene-3-O-acrylate-α-D-glucopentoaldo-1,4-furanose can be used as a building block for the development of novel drug delivery systems. The synthesized glycopolymers can be tailored to target specific diseases or conditions, improving the efficacy and bioavailability of therapeutic agents.
3. Used in Biomedical Applications:
1,2:5,6-di-O-isopropylidene-3-O-acrylate-α-D-glucopentoaldo-1,4-furanose can be utilized in the development of biomaterials for tissue engineering and regenerative medicine. The synthesized glycopolymers can mimic the natural extracellular matrix, promoting cell adhesion, proliferation, and differentiation.
4. Used in Material Science:
In material science, 1,2:5,6-di-O-isopropylidene-3-O-acrylate-α-D-glucopentoaldo-1,4-furanose can be used to create novel materials with unique properties, such as hydrogels, coatings, and films. These materials can find applications in various fields, including sensors, drug delivery, and environmental remediation.
5. Used in Food Industry:
1,2:5,6-di-O-isopropylidene-3-O-acrylate-α-D-glucopentoaldo-1,4-furanose can be employed in the food industry for the development of functional ingredients, such as prebiotics, texturizers, and stabilizers. The synthesized glycopolymers can enhance the nutritional value, texture, and shelf life of food products.
Check Digit Verification of cas no
The CAS Registry Mumber 40690-74-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,6,9 and 0 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 40690-74:
(7*4)+(6*0)+(5*6)+(4*9)+(3*0)+(2*7)+(1*4)=112
112 % 10 = 2
So 40690-74-2 is a valid CAS Registry Number.
40690-74-2Relevant articles and documents
Asymmetric Baylis-Hillman reaction using sugar acrylates - Synthesis of optically active α-methylene-β-hydroxy alkanoates
Radha Krishna, Palakodety,Kannan,Ilangovan,Sharma
, p. 829 - 837 (2001)
A study on the asymmetric Baylis-Hillman reaction of three chiral acrylates; 1,2:5,6-di-O-iso-propylidine-α-D-glucofuranose-3-acrylate 1, 2,3:5,6-di-O-iso-propylidine-α-D-mannofuranose-1-acrylate 2 and 1,2-O-iso-propylidine-5-O-tert-butyldimethylsilyl-α-D-xylofuranose-3 -acrylate 3, with various aldehydes was conducted, resulting in adducts with moderate diastereoselectivity (5-40% e.e.).
Tetrabutylammonium peroxydisulfate in organic synthesis; XI.1 A novel and selective approach to the oxidative deprotection of allyl ethers with tetrabutylammonium peroxydulfate
Chen,Ling,He,Peng
, p. 1772 - 1774 (2001)
A tetrabutylammonium peroxydisulfate-mediated oxidative procedure for the mild selective deprotection of allyl ethers to form the corresponding alcohols is described. The alcohols are obtained in yields of 81-85% and the method is compatible with several functional groups under these reaction conditions.
NANOPARTICLES FOR DRUG-DELIVERY
-
Page/Page column 54; 55, (2008/06/13)
This invention relates to a unique process for the preparation of polymeric nanoparticles with target molecules bonded to the surface of the particles and having sizes of up to 1000nm, preferably Inm to 400nm, more preferably Inm to 200nm, that are dispersed homogeneously in aqueous solution. To accomplish the above objective, the polymeric nanoparticles of the subject invention are prepared using a novel technique of microemulsion polymerization. The resulting aqueous solution of polymeric nanoparticles is comprised of about 1 to 100 parts per weight of water or buffer, about 1 to 80 parts per weight of polymeric nanoparticles, which the bio-active molecules are conjugated, about 0.001 to 10 parts per weight of emulsifier, and about 0.00001 to 5 parts per weight of radical initiator based on the weight of the solution. In the method of this invention, the target drug/target substance is covalently bonded to the polymeric nanoparticles to secure them from outer intervention in vivo or cell culture in vitro until they are exposed at the target site within the cell.
